Overview

Maintenance of Platelet Inhibition With Cangrelor

Status:
Completed

Trial end date:
2011-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to demonstrate that patients receiving cangrelor infusion before coronary artery bypass grafting have an acceptable safety profile and can undergo surgery without excessive bleeding peri-operatively.

Phase:

Phase 2

Details

Lead Sponsor:

The Medicines Company

Treatments:

Cangrelor